Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase I results of intratumoral administration of tigilanol tiglate support further development

Dec. 18, 2019

New analgesics identified at CerSci Therapeutics

Dec. 18, 2019

FronThera US Pharmaceuticals presents ENPP2 inhibitors

Dec. 18, 2019

Roche patents bacterial DNA gyrase and/or DNA topoisomerase IV inhibitors

Dec. 18, 2019

Peloton Therapeutics discloses new 5'-nucleotidase inhibitors

Dec. 18, 2019

D-amino-acid oxidase inhibitors discovered at SyneuRx International

Dec. 18, 2019

KIN-8194 overcomes BTK C481S-mediated ibrutinib resistance in preclinical models

Dec. 18, 2019

Cerevance and Takeda collaborate to advance novel therapies for gastrointestinal disorders

Dec. 18, 2019

Alnylam presents topline data from ILLUMINATE-A phase III study of lumasiran

Dec. 18, 2019

Topline data reported from phase II study of ARQ-151 in atopic dermatitis

Dec. 18, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...